Amanta Healthcar

43
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
186.00
-2.7 (-1.43%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 80.66 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 0.32% vs 3.79% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is -25.77% vs -16.92% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 41.66% vs 189.02% in Mar 2025

Compare Profit and Loss Results of Amanta Healthcar
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
287.00
188.00
99.00
52.66%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
287.00
188.00
99.00
52.66%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
1.00
-11.00
-1,100.00%
Raw Materials Consumed
107.00
87.00
20.00
22.99%
Power & Fuel Cost
22.00
2.00
20.00
1,000.00%
Employee Cost
42.00
12.00
30.00
250.00%
Operating Expenses
25.00
6.00
19.00
316.67%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
25.00
30.00
-5.00
-16.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
4.00
6.00
-2.00
-33.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
227.00
155.00
72.00
46.45%
Operating Profit (PBDIT) excl Other Income
59.00
33.00
26.00
78.79%
Other Income
3.00
13.00
-10.00
-76.92%
Operating Profit (PBDIT)
63.00
47.00
16.00
34.04%
Interest
20.00
3.00
17.00
566.67%
Profit before Depriciation and Tax
42.00
43.00
-1.00
-2.33%
Depreciation
18.00
2.00
16.00
800.00%
Profit Before Taxation & Exceptional Items
23.00
41.00
-18.00
-43.90%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
21.00
41.00
-20.00
-48.78%
Provision for Tax
6.00
9.00
-3.00
-33.33%
Profit After Tax
14.00
32.00
-18.00
-56.25%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
162.00
-134.00
-82.72%
Profit Available for appropriations
43.00
195.00
-152.00
-77.95%
Appropriations
43.00
195.00
-152.00
-77.95%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
4.33
9.57
-5.24
-54.75%
Profit And Loss - Net Sales
Net Sales 287.68 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 4.72% vs -2.01% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.86 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 0.32% vs 3.79% in Mar 2025

Profit And Loss - Interest
Interest 20.75 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -25.77% vs -16.92% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 14.88 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 41.66% vs 189.02% in Mar 2025

Footer loading